Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ES89 | ISIN: VGG1144D1336 | Ticker-Symbol: 29D
Lang & Schwarz
04.11.24
22:59 Uhr
0,001 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
ASIEN
1-Jahres-Chart
BIT BROTHER LIMITED Chart 1 Jahr
5-Tage-Chart
BIT BROTHER LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,0010,00104.11.
PR Newswire
453 Leser
Artikel bewerten:
(2)

Bit Brother Limited Plans to Appeal Delisting Determination by Nasdaq Hearing Panel

CHANGSHA, China, March 11, 2024 /PRNewswire/ -- Bit Brother Limited ("Bit Brother, " "We" or the "Company") (OTC Pink: BETSF), today announced its intention to appeal the recent delisting decision issued by the Hearing Panel of Nasdaq Stock Market ("Nasdaq").

We have recently received correspondence from shareholders across the globe who indicted that that they believe BETSF's recent financing activities have not harmed their interests. And it is with their support that we will be submitting our appeal.

As the cryptocurrency market experiences a bullish trend, BETSF remains focused on our digital currency operations, and shareholders are eagerly anticipating the company's growth in this thriving market. It is precisely during this opportune moment in the cryptocurrency market that Nasdaq's decision to delist BETSF should be considered as detrimental to shareholder interests. The timing of this Panel's decision is particularly unfortunate as shareholders expect significant returns from the company's operations in the cryptocurrency sector.

We were told on the social media platform that since the trading of our Class A ordinary shares was suspended on Nasdaq since March 7 many of our shareholders were unable to trade on OTC. They told us they could only sell shares and suffered a huge loss when the stock price fell sharply.

We intend to submit our appeal to Nasdaq no later than March 20, 2024. During this process, we sincerely invite all shareholders who share our concerns to stand with us,shareholders please email us with your valuable opinion at IR@bitbrother.com.

About Bit Brother Limited

Bit Brother Ltd is a multifaceted corporation with operations spanning business management in China and blockchain and cryptocurrency ventures in the United States. Within the U.S. jurisdiction, the company strategically manages and integrates cryptocurrency mining facilities. With a dedicated team of specialists, company has successfully expanded two mining ventures and is committed to further growth. For more information, please visit: www.bitbrother.com.

Forward-Looking Statements Disclaimer

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

Cision View original content:https://www.prnewswire.co.uk/news-releases/bit-brother-limited-plans-to-appeal-delisting-determination-by-nasdaq-hearing-panel-302085664.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.